
What We’re Reading: FDA Eyes Cancer Drug Process; Cigna Claims Review Criticized; US Bishops and Trans Care
The FDA wants to discourage the use of single-arm trials for accelerated approvals of oncology drugs; Cigna’s review system allows doctors to reject claims without reading them, an investigation shows; US bishops want to restrict gender transition care in Catholic hospitals.
FDA Seeks More Rigorous Approvals for Cancer Drugs
The FDA is proposing a more thorough process for accelerated approvals for cancer drugs,
Cigna Reject Claims Without Full Medical Review
In a
US Bishops Aims to Restrict Gender Transition Care
In a 14-page paper, titled “Moral Limits to the Technological Manipulation of the Human Body,” US bishops want to prohibit Catholic hospitals from providing gender transition care,
Related to this article








